1-4 of 4
Dejan Milosavljevic
Close
Sort by
Journal Articles

Isotype Matched Paired Immunoglobulin Suppression Identifies High Risk Multiple Myeloma Patients and Is Independent Of Bone Marrow Infiltration Suggesting Significant Variability In The HLC Matched Pair Suppressive Activity Of Individual Myeloma Clones

Heinz Ludwig, MD, Dejan Milosavljevic, Philip Young, Niklas Zojer, Stephen Harding
Journal: Blood
Blood (2013) 122 (21): 5352.
https://doi.org/10.1182/blood.V122.21.5352.5352
Published: 2013
Journal Articles

Usage of HLC-Ratio, FLC-Ratio, Ife, PBMC Infiltration and Isotype Suppression At Best Response Reveals Isotype Suppression As Most Powerful Parameter for Identification of Multiple Myeloma Patients with Long Survival

Heinz Ludwig, Georg Slavka, Wolfgang Hübl, Hugh Carr-Smith, Dejan Milosavljevic, Richard Hughes, Niklas Zojer, Stephen Harding
Journal: Blood
Blood (2012) 120 (21): 1817.
https://doi.org/10.1182/blood.V120.21.1817.1817
Published: 2012
Journal Articles

Intact Immunoglobulin or Fragments Thereof Can Be Detected in Urine in a Proportion of Patients with Multiple Myeloma and Are Associated with Reduced Survival At Presentation

Heinz Ludwig, Philip Young, Dejan Milosavljevic, Niklas Zojer, Wolfgang Hübl, Stephen Harding
Journal: Blood
Blood (2012) 120 (21): 1828.
https://doi.org/10.1182/blood.V120.21.1828.1828
Published: 2012
Journal Articles

Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)

Heinz Ludwig, MD, Jeffrey Faint, Niklas Zojer, Arthur R Bradwell, Philip Young, Dejan Milosavljevic, Wolfgang Hübl, Stephen Harding
Journal: Blood
Blood (2011) 118 (21): 2883.
https://doi.org/10.1182/blood.V118.21.2883.2883
Published: 2011